We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 63 start-ups with an aggregate funding of $4.6b. The average funding per company in this subset is $73.7m.
Last update to the database: Feb 18, 2025. See changelog.
7
Funding Rounds
$254.1m
Money raised
Owkin is a medical treatment and therapeutics company founded by Thomas Clozel. They develop artificial intelligence and machine learning tools to augment and develop medical and biological research.
4
Funding Rounds
$49.6m
Money raised
Inato matches the right sites to the right clinical research study, globally.
9
Funding Rounds
$82.6m
Money raised
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
1
Funding Rounds
Roquette is a French company focused on the production of plant-based food and nutrition ingredients for the food, beverage and pharmaceutical industries. The company was founded in 1933 by Dominique & Germain Roquette, and is headquartered in Lestrem, Nord-Pas-De-Calais, France.
3
Funding Rounds
$69.5m
Money raised
AI-powered drug discovery platform.
10
Funding Rounds
$62.4m
Money raised
A software solutions company providing bioinformatics solutions to life science and other sector
8
Funding Rounds
$572.6m
Money raised
Capsule is a healthcare platform transforming the pharmacy experience founded in 2016 by Eric Kinariwala.
1
Funding Rounds
$16.0m
Money raised
A pharmaceutical company that develops topical products to treat rare diseases
14
Funding Rounds
$332.5m
Money raised
Enterome is a pharmaceutical company founded in 2012 by Pierre Belichard.
8
Funding Rounds
$59.9m
Money raised
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat diseases linked to imbalances in the intestinal microbiome.
5
Funding Rounds
$98.6m
Money raised
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors
9
Funding Rounds
$40.9m
Money raised
Pili is a biotechnology company using microorganisms fed sugar to synthesize commercial quality dyes.
4
Funding Rounds
$241.9m
Money raised
Asklepios Biopharmaceutical is a company in North Carolina.
3
Funding Rounds
$191.8m
Money raised
Diabeloop is a Grenoble-based company founded in 2015.
5
Funding Rounds
$74.0m
Money raised
Depixus is an company of bioscientists based in Paris focusing in DNA research.
1
Funding Rounds
$1.2m
Money raised
Brainvectis is a biotechnology company developing treatments for neurodegenerative diseases through restoring cholesterol metabolism in the brain.
4
Funding Rounds
$179.5m
Money raised
Hifibio - High Fidelity Biology is a single cell technologies for drug discovery founded in 2013 by Liang Schweizer, Jeff He and Robert Nicol.
1
Funding Rounds
$4.0m
Money raised
Flash Therapeutics is a Toulouse-based biotechnology company founded in 2018.
2
Funding Rounds
$97.5m
Money raised
Develops small molecules drug candidates in infectious & metabolic diseases and oncology
2
Funding Rounds
$97.5m
Money raised
SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.
1
Funding Rounds
$7.7m
Money raised
LNC Therapeutics is the 1st company to harness the therapeutic potential of Christensenella. We have been focused on the fundamental causes of illnesses
3
Funding Rounds
$157.3m
Money raised
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.
4
Funding Rounds
$277.9m
Money raised
Immuno-modulatory antibodies
3
Funding Rounds
$4.2m
Money raised
Research company focused on developing cancer treatments with STING agonists.
4
Funding Rounds
$767.0m
Money raised
Vivet Therapeutics is a gene Therapy for Orphan Diseases founded in 2016 by Jean-Philippe Combal.
3
Funding Rounds
$19.9m
Money raised
Pharnext is a very well advanced clinical-stage biopharmaceutical company
1
Funding Rounds
$8.3m
Money raised
Exeliom is a gut microbiome modifiers founded by Benjamin Hadida, Harry Sokol, Patrick Gervais and Philippe Langella.
3
Funding Rounds
$61.0m
Money raised
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune and degenerative diseases.
2
Funding Rounds
$44.0m
Money raised
InnoSkel is a therapies for Rare Skeletal Diseases founded in 2020 by Elvire Gouze.
2
Funding Rounds
$14.2m
Money raised
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
2
Funding Rounds
$35.1m
Money raised
DiogenX is a regenerative diabetes treatment founded in 2019 by Jean-Pascal Tranié, Benjamin Charles and Patrick Collombat.
1
Funding Rounds
$1.1m
Money raised
MAbSilico is a Tours-based company founded by Anne Poupon, Thomas Bourquard, Astrid Musnier and Vincent Puard.
1
Funding Rounds
$16.0m
Money raised
Iktos is an AI for New Drug Design founded in 2016 by Yann Gaston-Mathe, Quentin Perron and Nicolas Do Huu.
1
Funding Rounds
$16.5m
Money raised
Lysogene is a company by Karen Aiach.
2
Funding Rounds
$10.7m
Money raised
Kayentis is a data capture for clinical trials founded in 2003 by Philippe Berna.
2
Funding Rounds
$24.1m
Money raised
MedicAnimal is a Willesden-based company founded in 2007.
2
Funding Rounds
$13.0m
Money raised
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.
2
Funding Rounds
$831.6k
Money raised
Xenothera SAS is an antibody for infection/oncology founded by Odile Duvaux.
5
Funding Rounds
$5.7m
Money raised
EverImmune is a microbial Immunotherapy founded in 2016.
2
Funding Rounds
$179.6m
Money raised
Mnemo Therapeutics is a biotechnology company focused on discovering and developing immune-based therapies.
2
Funding Rounds
$7.7m
Money raised
Biopharmaceutical company focused on developing Rapid Transfer Systems (RTS) solutions.
1
Funding Rounds
$6.5m
Money raised
Lucine has the ambition to transform and improve patient's health.
1
Funding Rounds
$2.6m
Money raised
Nosopharm is an anti-infectives, Peptide founded in 2009 by Philippe VILLAIN-GUILLOT.
2
Funding Rounds
$29.5m
Money raised
Brenus Pharma is a cancer vaccine developer founded in 2021 by Benoit Pinteur.
1
Funding Rounds
$17.7k
Money raised
LXRepair is a Grenoble-based medical diagnostics company developing personalized medicine and diagnostics through DNA enzyme signature analysis.
1
Funding Rounds
$4.7m
Money raised
Oncodesign is a preclinical services founded in 1995.
1
Funding Rounds
$20.3m
Money raised
Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
3
Funding Rounds
$39.6m
Money raised
Mablink Bioscience is an antibody-drug Conjugates founded in 2018.
2
Funding Rounds
$191.3m
Money raised
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
1
Funding Rounds
$22.6m
Money raised
Diagnostic tests in oncology utilizing the immune contexture of cancers.
2
Funding Rounds
$62.7m
Money raised
Abivax is a viral diseases founded in 2013.
1
Funding Rounds
$9.9m
Money raised
Advanced Biodesign is a contract Research & Development founded in 2010.
1
Funding Rounds
$2.3m
Money raised
Phagos Biotech is a company founded in 2021.
1
Funding Rounds
$2.3m
Money raised
Syndivia is a Strasbourg-based company.
1
Funding Rounds
$2.1m
Money raised
Provider of 3D printing systems for the pharmaceutical sector.
1
Funding Rounds
$3.7m
Money raised
Le Comptoir Des Pharmacies is an inventory management platform for pharmacists founded in 2016.
1
Funding Rounds
$6.5m
Money raised
Vaxinano is a prophylactic and therapeutic nasal vaccines developer founded in 2016 by Didier Betbeder.
1
Funding Rounds
$10.5m
Money raised
MedDay is a Paris-based company founded in 2011.
1
Funding Rounds
$1.3m
Money raised
Biotech company providing large-scale GMP manufacturing of extracellular vesicles for nanomedicine.
1
Funding Rounds
$13.5m
Money raised
Superbranche is a manufacture of superparamagnetic nanoparticles for cancer treatment founded in 2019 by Delphine Felder Flesch.
1
Funding Rounds
$9.9m
Money raised
BioDesign is a Lyon-based company.
1
Funding Rounds
$2.2m
Money raised
Wellium is a France-based company.
1
Funding Rounds
$1.6m
Money raised
CVasThera is a France-based company in the pharmaceutical industry.
Enter your email and get access to 71,000 + technology companies you can partner with.